The Investor Summit: Bee Vectoring Technologies: Invitation to the Q2 Virtual Investor Summit
Mississauga, Ontario (Newsfile Corp. - May 11, 2021) - Bee Vectoring Technologies (CSE: BEE) today announced that Ashish Malik will be attending the Q2 Virtual Investor Summit. Event Location
About Bee Vectoring Technologies
BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market. BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. BVT s award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally-derived pesticides (called biologicals) to be delivered directly, continuously and daily throughout the bloom process, providing improved crop p
The Investor Summit: AzurRx BioPharma Announces Participation in the Q2 Virtual Investor Summit
Delray Beach, Florida (Newsfile Corp. - May 11, 2021) -
AzurRx BioPharma (NASDAQ: AZRX) today announced that James Sapirstein, Chairman, President, and CEO will be attending the Q2 Virtual Investor Summit. Event Location
About AzurRx BioPharma
AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company has a pipeline of three gut-restricted GI assets. The lead therapeutic candidate is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis. AzurRx is also advancing two clinical programs using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor; FW-1022, for COVID-19 GI infections and FW-420, for Grade 1 Immune Checkpoint Inhibi
The Investor Summit: Crew Energy Inc. Announces Participation in the Q2 Virtual Investor Summit
Calgary, Alberta (Newsfile Corp. - May 11, 2021) - Crew Energy Inc. (TSX: CR) today announced that Dale Shwed and John Leach will be attending the Q2 Virtual Investor Summit. Event Location
About Crew Energy Inc.
Crew is a growth-oriented oil and natural gas producer, committed to pursuing sustainable per share growth through a balanced mix of financially and socially responsible exploration and development complemented by strategic acquisitions. The Company s operations are primarily focused in the vast Montney resource, situated in northeast British Columbia, and include a large contiguous land base. Greater Septimus along with Groundbirch and the light oil area at Tower in British Columbia offer significant development potential over the long-term. The Company has access to diversified markets with operated infrastructure and access to multiple pipeline egress options. Crew ad
The Investor Summit: Vidler Water Resources, Inc. Announces Participation in the Q2 Virtual Investor Summit
Carson City, Nevada (Newsfile Corp. - May 11, 2021) - Vidler Water Resources, Inc. (NASDAQ: VWTR) today announced that Dorothy Timian-Palmer; President & Chief Executive Officer will be attending the Q2 Virtual Investor Summit. Event Location
About Vidler Water Resources, Inc.
Our business is to source, develop and provide sustainable potable water resources to fast-growing communities throughout the Southwest U.S. that lack, or are running short of, available water resources. We conduct our business by working closely with many constituents in these communities: regulators, utilities, Native North American tribes, community leaders, residential and commercial developers and alternative energy companies. We ensure the water resources we develop and sell are sustainable and provide benefit to the citizens of the communities and regions we serve.
The Investor Summit: Miravo Healthcare Invites You to Join Us at the Q2 Virtual Investor Summit Location
About Miravo Healthcare
About Miravo HealthcareMiravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company s products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company s manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. For additional information, please visit www.miravohe